Old drug, new hope: testing methylene blue against deadly septic shock
NCT ID NCT07264543
Summary
This study is a small, first-step trial to see if it's practical to run a larger study on methylene blue for septic shock. It aims to see if this old, safe drug can improve blood flow in the body's smallest vessels when given early. The study will enroll 50 adults with septic shock to test the treatment plan and monitor for side effects, paving the way for future research on whether it saves lives or shortens hospital stays.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Irmandade da Santa Casa de Misericórdia de Curitiba
RECRUITINGCuritiba, Paraná, 80010-030, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.